Adia Nutrition Advances Towards OTCQB Uplisting with Third-Party Audit and Provides Roadmap to Listing on Nasdaq Small Cap
Adia Nutrition (OTC Pink: ADIA) has appointed a PCAOB accounting firm for a comprehensive third-party audit as part of its strategy to uplist from OTC Pink Sheets to the OTCQB Venture Market. This move aims to enhance visibility and attract more investors while demonstrating the company's commitment to transparency.
The uplisting to OTCQB is expected to provide several benefits, including increased transparency through higher reporting standards, greater market liquidity, enhanced investor confidence, and broader accessibility to investors. The company has outlined a roadmap to eventually list on the Nasdaq Small Cap, which involves completing the OTCQB uplisting, establishing SEC reporting, scaling operations to meet Nasdaq's standards, and ensuring adequate shareholder equity and public float.
Adia Nutrition (OTC Pink: ADIA) ha nominato una società di contabilità PCAOB per un audit completo di terza parte come parte della sua strategia per passare dalle OTC Pink Sheets al OTCQB Venture Market. Questa mossa mira a migliorare la visibilità e attrarre più investitori, dimostrando al contempo l'impegno dell'azienda per la trasparenza.
La promozione all'OTCQB dovrebbe offrire diversi vantaggi, tra cui una maggiore trasparenza attraverso standard di reporting più elevati, maggiore liquidità di mercato, rafforzamento della fiducia degli investitori e una più ampia accessibilità per gli investitori. L'azienda ha delineato un piano per alla fine quotarsi al Nasdaq Small Cap, che comporta il completamento della promozione all'OTCQB, l'istituzione del reporting SEC, l'espansione delle operazioni per soddisfare gli standard del Nasdaq e l'assicurazione di un adeguato capitale azionario e flottante pubblico.
Adia Nutrition (OTC Pink: ADIA) ha nombrado a una firma de contabilidad PCAOB para una auditoría exhaustiva de terceros como parte de su estrategia para pasar de las OTC Pink Sheets al OTCQB Venture Market. Este movimiento tiene como objetivo mejorar la visibilidad y atraer a más inversores, al mismo tiempo que demuestra el compromiso de la empresa con la transparencia.
El paso al OTCQB se espera que proporcione varios beneficios, incluyendo mayor transparencia a través de estándares de informes más altos, mayor liquidez en el mercado, confianza aumentada de los inversores y mayor accesibilidad para los inversores. La empresa ha delineado una hoja de ruta para eventualmente cotizar en el Nasdaq Small Cap, lo que implica completar la promoción al OTCQB, establecer informes de la SEC, escalar operaciones para cumplir con los estándares del Nasdaq y garantizar un capital social adecuado y flotante público.
Adia Nutrition (OTC Pink: ADIA)는 OTC Pink Sheets에서 OTCQB 벤처 마켓으로의 전환을 위한 전략의 일환으로 PCAOB 회계 회사를 선정하여 포괄적인 제3자 감사 를 진행할 예정입니다. 이 조치는 회사의 투명성에 대한 헌신을 보여주면서 가시성을 높이고 더 많은 투자자를 유치하는 것을 목표로 하고 있습니다.
OTCQB로의 상장은 더 높은 보고 기준을 통해 더 큰 투명성, 더 나은 시장 유동성, 투자자 신뢰 증대 및 더 넓은 접근성을 제공할 것으로 기대됩니다. 회사는 궁극적으로 Nasdaq Small Cap에 상장하기 위한 로드맵을 제시하였으며, 이는 OTCQB 상장 완료, SEC 보고 설정, Nasdaq의 기준을 충족하기 위한 운영 확장 및 적절한 주주 자본과 공공 유통을 보장하는 것을 포함합니다.
Adia Nutrition (OTC Pink: ADIA) a nommé un cabinet comptable PCAOB pour un audit complet par un tiers dans le cadre de sa stratégie de passage des OTC Pink Sheets au OTCQB Venture Market. Cette initiative vise à améliorer la visibilité et à attirer davantage d'investisseurs tout en démontrant l'engagement de l'entreprise envers la transparence.
Le passage au OTCQB devrait offrir plusieurs avantages, notamment une plus grande transparence grâce à des normes de reporting plus élevées, une meilleure liquidité de marché, une confiance accrue des investisseurs et un accès élargi aux investisseurs. L'entreprise a tracé une feuille de route pour éventuellement s'inscrire au Nasdaq Small Cap, ce qui implique de finaliser l'inscription au OTCQB, d'établir des rapports auprès de la SEC, d'accroître ses opérations pour respecter les normes du Nasdaq et de garantir un capital-actions adéquat ainsi qu'un flottant public approprié.
Adia Nutrition (OTC Pink: ADIA) hat eine PCAOB- Wirtschaftsprüfungsgesellschaft beauftragt, um im Rahmen seiner Strategie eine umfassende Drittanbieter-Prüfung durchzuführen, um von den OTC Pink Sheets zum OTCQB Venture Market aufzulisten. Diese Maßnahme soll die Sichtbarkeit erhöhen und mehr Investoren anziehen, während sie das Engagement des Unternehmens für Transparenz demonstriert.
Die Uplisting zum OTCQB wird voraussichtlich mehrere Vorteile bieten, darunter erhöhte Transparenz durch höhere Berichtstandards, größere Marktliquidität, gesteigertes Vertrauen der Investoren und breitere Zugänglichkeit für Investoren. Das Unternehmen hat einen Fahrplan skizziert, um letztendlich an der Nasdaq Small Cap notiert zu werden, der den Abschluss des Uplisting an der OTCQB, die Einrichtung von SEC-Berichterstattung, die Skalierung der Operationen zur Erfüllung der Nasdaq-Standards und die Sicherstellung einer angemessenen Eigenkapitalquote und eines öffentlichen Floats umfasst.
- Strategic uplisting plan from OTC Pink to OTCQB, with future Nasdaq Small Cap listing goal
- Appointment of PCAOB accounting firm for third-party audit
- Potential for increased trading volume and market liquidity
- Plan to remove shell status and register as 15c211 filing stock
- Currently trading on less regulated OTC Pink Sheets
- Multiple regulatory hurdles and requirements before achieving Nasdaq listing
- Additional compliance costs associated with uplisting process
WINTER PARK, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Adia Nutrition Inc. (OTC Pink: ADIA), an innovator nutritional products and medical treatments, has announced that through collaboration with Adia’s accountant, Adia has appointed a PCAOB (Public Company Accounting Oversight Board) accounting firm to conduct a comprehensive third-party audit. This strategic move is part of Adia's plan to uplist its shares from the OTC Pink Sheets to the OTCQB Venture Market, aiming to enhance visibility, attract a broader investor base, and reflect the company's commitment to transparency and growth.
"Having a fully running business model for the past year, we are now taking this significant step towards uplisting to OTCQB," said Larry Powalisz, CEO of Adia Nutrition. "This audit will not only validate our financial health but also open doors to a new crowd of investors who believe in our mission to revolutionize health and wellness through our unique offerings."
The transition to OTCQB is a testament to Adia Nutrition's progress and operational maturity, offering several advantages:
- Increased Transparency: Uplisting requires adherence to higher reporting standards, providing investors with more detailed and timely financial data.
- Greater Market Liquidity: Shares on OTCQB typically experience increased trading volumes, offering better liquidity for shareholders.
- Enhanced Investor Confidence: The audit and uplisting signal to investors that Adia Nutrition operates with integrity and is poised for continued growth.
- Broader Accessibility: The OTCQB platform is more accessible to a wider range of investors, including those who might not typically invest in Pink Sheets securities due to perceived risks.
Adia Nutrition's diverse portfolio, including its groundbreaking work in stem cell therapy through Adia Med, has positioned the company as a pioneer in the health sector. The anticipated uplisting is expected to catalyze further investment interest, remove Adia’s shell status, and register as a 15c211 filing stock.
"We are excited about the potential this uplisting brings," added Powalisz. "It's not just about elevating our stock; it's about bringing our story and our science to a broader audience who can appreciate and support our vision. ADIA will be working to expedite the uplisting process as quickly as possible."
Adia Nutrition's roadmap to listing on Nasdaq Small Cap involves several strategic steps: first, achieving a successful uplisting to the OTCQB by completing a third-party audit and establishing SEC reporting. This is followed by scaling operations to meet Nasdaq's stringent financial and governance standards, which includes ensuring adequate shareholder equity and public share float. The process culminates in submitting a formal application to Nasdaq, gaining approval, and executing a seamless transition from OTCQB to Nasdaq, while committing to ongoing compliance with Nasdaq's listing requirements.
For media inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Website: www.adia-med.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/bbda4e45-8749-4615-b917-456858613cec
FAQ
What steps is ADIA taking to uplist from OTC Pink to OTCQB?
What are the benefits of ADIA's planned uplisting to OTCQB?
What is ADIA's timeline for uplisting to Nasdaq Small Cap?
How will ADIA's uplisting affect trading volume and liquidity?
